Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Hypersensitivity Reaction

Free Subscription Articles published in Chest Retrieve available abstracts of 66 articles: HTML format

Single Articles

April 2026
1. WU Z, Yazbeck L, Smith DJF, Holt K, et al
   Characterising cough and its response to therapy in hypersensitivity pneumonitis.
   Chest. 2026 Apr 8:S0012-3692(26)00439-3. doi: 10.1016/j.chest.2026.
   PubMed     Abstract available
   
   
   
2. PEIRCE AM, Hogan CK, Weinstein JB, Seelye SM, et al
   Clinician Views on Inhaler Substitution in the Veterans Health Administration.
   Chest. 2026;169:1039-1050.
   PubMed     Abstract available
   
   
   
3. CHAO WC, Liao SY
   Comparative Outcomes and Side Effects of Immunosuppressants and Tumor Necrosis Factor Inhibitors in Sarcoidosis: A Real-World Data Analysis.
   Chest. 2026;169:1006-1017.
   PubMed     Abstract available
   
   
   March 2026
4. KONKOL SB, Huang Y, Ma SF, Humphries S, et al
   MMP12 Improves the Differentiation of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis and Associates with Antigen Response Pathways.
   Chest. 2026 Mar 7:S0012-3692(26)00286-2. doi: 10.1016/j.chest.2026.
   PubMed    
   
   
   January 2026
5. FREEDMAN M, Odega UK, Ko A, Mannem H, et al
   Arterial Stenosis From Sarcoidosis-Associated Adenopathy and Fibrosing Mediastinitis Leading to Pulmonary Infarction.
   Chest. 2026;169:e1-e4.
   PubMed     Abstract available
   
   
   
6. HENA KM, Barkes B, Heinrich F, Kogan R, et al
   An Inventory of Clinical Sarcoidosis Status in the United States.
   Chest. 2026;169:159-173.
   PubMed     Abstract available
   
   
   December 2025
7. MUEGGE CN, Min B, Mrad A, Ianazzo E, et al
   Radiographic Fibrosis Extent Identifies Immunomodulatory Treatment Response in Hypersensitivity Pneumonitis.
   Chest. 2025 Dec 18:S0012-3692(25)05927-6. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   
8. TAILLE C, Hamidi F, Heddebaut N, Pote N, et al
   Impact of mepolizumab on airway remodeling and inflammation in severe eosinophilic asthma.
   Chest. 2025 Dec 5:S0012-3692(25)05814-3. doi: 10.1016/j.chest.2025.
   PubMed     Abstract available
   
   
   
9. CANT E, Bottier M, Shuttleworth M, Stobo J, et al
   Inflammatory and Mucociliary Dysfunction-Based Endotypes Across the Spectrum of Chronic Airway Diseases.
   Chest. 2025;168:1317-1329.
   PubMed     Abstract available
   
   
   
10. MATHIAS KR, Eakin MN, Hauschildt KE, Chen ES, et al
    The Impact of the Unknown: Patient Experiences With Uncertainty in Sarcoidosis.
    Chest. 2025;168:1395-1403.
    PubMed     Abstract available
    
    
    
11. JOUANJAN L, Terschluse C, Zissel G, Agarwal P, et al
    Beryllium Lymphocyte Proliferation Test: Differential Diagnosis of Sarcoidosis and Chronic Beryllium Disease.
    Chest. 2025;168:1404-1414.
    PubMed     Abstract available
    
    
    November 2025
12. CELIS-PRECIADO CA, Hamou Kuijpers EB, Ramakrishnan S, Howell I, et al
    Applying precision medicine to the heterogeneity of asthma attacks.
    Chest. 2025 Nov 13:S0012-3692(25)05695-8. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
13. KENDZERSKA T, Talarico R, Povitz M, Blades K, et al
    Association Between a Recalled Positive Airway Pressure Device and Obstructive Lung Disease: A Province-Based Study.
    Chest. 2025;168:1231-1247.
    PubMed     Abstract available
    
    
    September 2025
14. TEELUCKSINGH S, Davis A, Nelson-Piercy C
    Asthma and Pregnancy: A Narrative Review.
    Chest. 2025 Sep 25:S0012-3692(25)05382-6. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
15. OBERLE AJ, Abbas F, Adrish M, Agache I, et al
    Biologic Management in Severe Asthma for Adults: An American College of Chest Physician Clinical Practice Guideline.
    Chest. 2025 Sep 24:S0012-3692(25)05380-2. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
16. NOBLE JH, Warhurst S, Cullen R, Sayers R, et al
    THE DOSE-RESPONSE OF INHALED CORTICOSTEROIDS IN COMBINATION ICS/LABA MAINTENANCE THERAPY FOR ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Chest. 2025 Sep 3:S0012-3692(25)05145-1. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
17. VANDERHOEF D, Marka N, Langworthy B, Kapur N, et al
    Characterizing Patients With Sarcoidosis With Obstructive Respiratory Physiology.
    Chest. 2025;168:688-696.
    PubMed     Abstract available
    
    
    August 2025
18. SHEIKH S, Eisner M, Kelin W, Kilbarger J, et al
    Intermittent Asthma and Risk of Severe Exacerbation in Children.
    Chest. 2025 Aug 27:S0012-3692(25)05124-4. doi: 10.1016/j.chest.2025.07.4089.
    PubMed     Abstract available
    
    
    
19. COUSSEMENT A, Goeminne P, De Crem N, Houben E, et al
    A 63-Year-Old Man With Persistent Chest Constriction on Exercise.
    Chest. 2025;168:e29-e33.
    PubMed     Abstract available
    
    
    
20. TOUMPANAKIS D, Karagiannis K, Paredi P, Bikov A, et al
    Contribution of Peripheral Airways Dysfunction to Poor Quality of Life in Sarcoidosis.
    Chest. 2025;168:423-434.
    PubMed     Abstract available
    
    
    July 2025
21. DONNELLY R, Franciosi AN, Forde SH, McDermott M, et al
    Deciphering the Role of Fluorodeoxyglucose-Positron Emission Tomography/CT Imaging in the Management of Sarcoidosis.
    Chest. 2025;168:146-155.
    PubMed     Abstract available
    
    
    May 2025
22. SERAJEDDINI H, Thakar A, Kjarsgaard M, Huang C, et al
    Sputum Cellularity and MRI Ventilation Defects in Severe Asthma.
    Chest. 2025 May 20:S0012-3692(25)00648-8. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
23. YADAV CP, Chakraborty A, Price DB, Mien Lim LH, et al
    Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis.
    Chest. 2025 May 19:S0012-3692(25)00647-6. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
24. SEEDAHMED MI, Albirair MT, Baugh AD, Gellad WF, et al
    Trends in All-Cause Mortality Among US Veterans With Sarcoidosis, 2004-2022.
    Chest. 2025;167:1416-1427.
    PubMed     Abstract available
    
    
    April 2025
25. PELAIA G, Jackson DJ, Nair P, Emmanuel B, et al
    XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma.
    Chest. 2025 Apr 19:S0012-3692(25)00441-6. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available
    
    
    
26. AGARWAL R, Muthu V, Sehgal IS
    Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.
    Chest. 2025;167:e143.
    PubMed    
    
    
    
27. SANGANI R, Bosch NA, Govender P, Scarpato B, et al
    Sarcoidosis Treatment Patterns in the United States: 2016-2022.
    Chest. 2025;167:1099-1106.
    PubMed     Abstract available
    
    
    March 2025
28. FARES J, El Fadel O, Zhao J, Li M, et al
    Mortality and Health Outcomes Among Patients With Sarcoidosis Treated With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Chest. 2025;167:772-780.
    PubMed     Abstract available
    
    
    
29. ANDERSEN JD, Lyster ML, Holst MK, Henriksen DP, et al
    Risk of Pulmonary Diseases in Osteogenesis Imperfecta in Denmark: A Register-Based Cohort Study.
    Chest. 2025;167:806-817.
    PubMed     Abstract available
    
    
    February 2025
30. MUSTAFA AM, Psoter KJ, Koehler K, Lin N, et al
    The Association Between Air Pollution and Lung Function in Sarcoidosis and Implications for Health Disparities.
    Chest. 2025;167:507-517.
    PubMed     Abstract available
    
    
    January 2025
31. GAZENGEL P, Hindre R, Jeny F, Mendes S, et al
    Sarcoidosis and Emergency Hospitalization.
    Chest. 2025;167:164-171.
    PubMed     Abstract available
    
    
    
32. GRANT-ORSER A, Asmussen M, Marinescu DC, Hague CJ, et al
    BAL Fluid Cellular Analysis and Radiologic Patterns in Patients With Fibrotic Interstitial Lung Disease.
    Chest. 2025;167:172-182.
    PubMed     Abstract available
    
    
    December 2024
33. COSIO BG, Iglesias A, Shafiek H, Mosteiro M, et al
    The role of bronchial biopsy in the prediction of response to biological therapy in severe uncontrolled asthma: a prospective study.
    Chest. 2024 Dec 30:S0012-3692(24)05733-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
34. CHAN R, Gochicoa-Rangel L, Cottini M, Comberiati P, et al
    Ascertainment of small airway dysfunction using oscillometry to better define asthma control and future risk: are we ready to implement it in clinical practice?
    Chest. 2024 Dec 27:S0012-3692(24)05728-3. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
35. JESENAK M, Bobcakova DA, Djukanovic R, Gaga M, et al
    Promoting Prevention and Targeting Remission of Asthma A EUFOREA Consensus Statement on Raising the Bar in Asthma Care.
    Chest. 2024 Dec 11:S0012-3692(24)05617-4. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
36. BIERBRIER J, Gerstein E, Whitmore GA, Vandemheen KL, et al
    Impact of Dyspnea on Adults With Respiratory Symptoms Without a Defined Diagnosis.
    Chest. 2024;166:1296-1308.
    PubMed     Abstract available
    
    
    November 2024
37. KHALAF Z, Saglani S, Bloom CI
    Implementation and effectiveness of guideline-recommended clinical activities for children with asthma: population-based cohort.
    Chest. 2024 Nov 6:S0012-3692(24)05442-4. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
38. ZHUO B, Ran S, Qian AM, Zhang J, et al
    Air Pollution Metabolomic Signatures and Chronic Respiratory Diseases Risk: A Longitudinal Study.
    Chest. 2024;166:975-986.
    PubMed     Abstract available
    
    
    
39. BREMS JH, Vick J, Ashana D, Beach MC, et al
    "Against Medical Advice" Discharges After Respiratory-Related Hospitalizations: Strategies for Respectful Care.
    Chest. 2024;166:1155-1161.
    PubMed     Abstract available
    
    
    
40. ROSSIDES M, Kullberg S, Arkema EV
    History and Familial Aggregation of Immune-Mediated Diseases in Sarcoidosis: A Register-Based Case-Control-Family Study.
    Chest. 2024;166:1082-1092.
    PubMed     Abstract available
    
    
    
41. BENN BS, Lippitt WL, Cortopassi I, Balasubramani GK, et al
    Understanding the Added Value of High-Resolution CT Beyond Chest X-Ray in Determining Extent of Physiologic Impairment.
    Chest. 2024;166:1093-1107.
    PubMed     Abstract available
    
    
    October 2024
42. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
    Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
    PubMed     Abstract available
    
    
    
43. SHARMA V, Ricketts HC, McCombie L, Brosnahan N, et al
    A one-year weight management programme for difficult-to-treat asthma with obesity: a randomised controlled study.
    Chest. 2024 Oct 18:S0012-3692(24)05320-0. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
44. CARR TF
    The Lifelong Burden of Severe Childhood Asthma.
    Chest. 2024;166:653-654.
    PubMed    
    
    
    September 2024
45. COUILLARD S, Jackson DJ, Pavord ID, Wechsler ME, et al
    How I do it. Choosing the right biologic for the right patient with severe asthma.
    Chest. 2024 Sep 6:S0012-3692(24)05139-0. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
46. KATTIH Z, Fernandes M, Alvarez Villela MA, Machnicki S, et al
    Syncope in an Otherwise Healthy 74-Year-Old Woman.
    Chest. 2024;166:e79-e82.
    PubMed     Abstract available
    
    
    
47. ARGER N, Sharp M, Bonham C, Patel D, et al
    Sarcoidosis Faculty Development: The Pipeline Is Running Dry.
    Chest. 2024;166:528-531.
    PubMed    
    
    
    August 2024
48. RHOADS SL, Mohan A
    A Novel Examination of Azithromycin as a Low-Cost Intervention to Achieve Remission in Asthma.
    Chest. 2024;166:241-242.
    PubMed    
    
    
    
49. BUSHWELLER L, Hodges S, Meyer L, Reed J, et al
    Partnering With Patients With Sarcoidosis to Implement a Community Advisory Board.
    Chest. 2024;166:343-351.
    PubMed     Abstract available
    
    
    July 2024
50. PATTI MA, Henderson NB, Phipatanakul W, Jackson-Browne M, et al
    Recommendations for Clinicians to Combat Environmental Disparities in Pediatric Asthma: A Review.
    Chest. 2024 Jul 24:S0012-3692(24)04845-1. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
51. VAN GANSE E, Louis R
    International Severe Asthma Registry: Closer to the Full Picture of Asthma Care and Outcomes?
    Chest. 2024;166:3-4.
    PubMed    
    
    
    June 2024
52. SAVRAN O, Bonnelykke K, Ulrik CS
    Characteristics of adults with severe asthma in childhood - A 60-year Follow-up Study.
    Chest. 2024 Jun 28:S0012-3692(24)00806-7. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
53. SHAH JT, Richardson WM, Mazori DR, Mittal L, et al
    Sarcoidosis Is Associated With Hematologic Comorbidities: A Cross-Sectional Study in the All of Us Research Program.
    Chest. 2024;165:1444-1447.
    PubMed    
    
    
    May 2024
54. WU WW, Wang G
    How Much Do We Know About Clinical Response and Remission to Add-On Biologics in Severe Asthma in a Real-World Setting.
    Chest. 2024;165:e157-e158.
    PubMed    
    
    
    
55. FIORINI V, Hu B, Sun Y, Yu S, et al
    Circulating Mitochondrial DNA Is Associated With High Levels of Fatigue in Two Independent Sarcoidosis Cohorts.
    Chest. 2024;165:1174-1185.
    PubMed     Abstract available
    
    
    April 2024
56. ASH SY
    Quantitative Imaging and Bronchial Thermoplasty: Technically Impressive But Clinically Uncertain.
    Chest. 2024;165:755-756.
    PubMed    
    
    
    
57. SAMANT M, Krings JG, Lew D, Goss CW, et al
    Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders.
    Chest. 2024;165:775-784.
    PubMed     Abstract available
    
    
    
58. BRIXEY AG, Oh AS, Alsamarraie A, Chung JH, et al
    Pictorial Review of Fibrotic Interstitial Lung Disease on High-Resolution CT Scan and Updated Classification.
    Chest. 2024;165:908-923.
    PubMed     Abstract available
    
    
    
59. OBI ON, Alqalyoobi S, Maddipati V, Lower EE, et al
    High-Resolution CT Scan Fibrotic Patterns in Stage IV Pulmonary Sarcoidosis: Impact on Pulmonary Function and Survival.
    Chest. 2024;165:892-907.
    PubMed     Abstract available
    
    
    March 2024
60. GUPTA S, Couillard S, Digby G, Tse SM, et al
    Climate Change and Inhaler Selection in Patients With Respiratory Disease.
    Chest. 2024;165:503-506.
    PubMed    
    
    
    
61. SAHAY S
    Rebuttal From Dr Sahay.
    Chest. 2024;165:498-499.
    PubMed    
    
    
    February 2024
62. THOMAS D, McDonald VM, Stevens S, Baraket M, et al
    Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial.
    Chest. 2024 Feb 29:S0012-3692(24)00284-8. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
63. LEE TY, Price D, Yadav CP, Roy R, et al
    International variation in severe exacerbation rates in patients with severe asthma.
    Chest. 2024 Feb 21:S0012-3692(24)00264-2. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    
64. WU TD, Diamant Z, Hanania NA
    An Update on Patient-Reported Outcomes in Asthma.
    Chest. 2024 Feb 14:S0012-3692(24)00156-9. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    January 2024
65. YAFASOVA A, Fosbol EL, Gustafsson F, Krintel SB, et al
    Long-term risk of venous thromboembolism in sarcoidosis: a nationwide cohort study.
    Chest. 2024 Jan 29:S0012-3692(24)00134-X. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available
    
    
    December 2023
66. NAEGER S, Pool V, Macina D
    Increased burden of pertussis among adolescents and adults with asthma or COPD in the US, 2007-2019.
    Chest. 2023 Dec 19:S0012-3692(23)05934-2. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum